| Literature DB >> 7248820 |
E Martínez-Aguirre, J A Wikinski, A Bello, J Izquierdo, A Garcia, H Velarde.
Abstract
The drug 4-aminopyridine (4-AP) at a dose of 0.2 mg . kg-1 body weight intravenously is an effective antagonist of non-depolarizing neuromuscular blockade. We studied its cardiovascular effects in the canine heart using a right-heart bypass with extracorporeal circulation in seven dogs. This study demonstrates that 4-aminopyridine significantly augments arterial blood pressure, left ventricular dp/dt maximum, as well as left ventricular pressure at dp/dt mx. The highest values were obtained between two and 20 minutes after administration of 4-AP. Left ventricular end-diastolic pressure diminished slightly, but this was not statistically significant. Although the exact mechanism of action of 4-AP is not known, its positive inotropic effects may be of value in the reversal of non-depolarizing neuromuscular blockade in patients with impaired myocardial function of diverse aetiologies and it would be contra-indicated in patients with arterial hypertension and/or coronary artery disease.Entities:
Mesh:
Substances:
Year: 1981 PMID: 7248820 DOI: 10.1007/bf03007253
Source DB: PubMed Journal: Can Anaesth Soc J ISSN: 0008-2856